(RA) . (Nutrition Journal) . RA 100 () 197. , , , . . 168 , 1 , , , , . RA , . , .
[= ] . (Neural Engineering) . , . , , , ·· · · · , , , , . , , , , . (University of Minnesota Twin Cities) (Somatosensory cortex) . , . , , . , . (jaebaekchoi@naver.com) [ . - ]
() . ( ) . . ?2012 100 , · . . . ' ' 73.9% , 22.2% . ' ' 26.1%, 13% . , . . , . , , . , · . . . , . (40 2300~2500) . 30 . . , .
[ ]2022 3 . , , . B . A+() 10 B . B1, B2, B6 , , , , , , . B1 . B1 8, B1 4 . . A+ D, , . ikson@heraldcorp.com
. . . , . .7 (Molecular Psychiatry) . , . (SSRI) . 1 30% . , ? . = . , . . , . . , . . . , . , . --(HPA) . , HPA . HPA 40~60%, 20~40% . . . (selective serotonin reuptake inhibitor, SSRI) . SSRI … [+117 chars]
19 17(18236) 4 . 19 95% . . 19 . 3 1 . 65 40% . , 19 . 19 . 19 2 . 6 (Hypertension) mRNA 3 86% . 2 . 50 4 , . , . 19 ? 19 . . . . . , . . 19 . . . . . , . , . 19 . ( )
() [// ]. , , . . , , , . , . 60% . 40% . () . Q. ?, . Q. ?, , , , , .Q. . ?. . Q. ?, , . , . Q. ?2~3mm . , . . . . 1cm . . . Q. ?1~2 . Q. ?. . . Q. ?, . Q. ?. . 3 , . Q. , ?. . , . = (… [+1 chars]
(IBD) (3) , , (2) Clinical Gastroenterology & Hepatology 18 . Michael J. Buie IBD, (CD) (UC) . (AAPC) . , , (3), , , (2), (1) . 3 IBD, CD, UC 1 ( AAPC : -0.13, 0.20, 0.02%). , 2, 1 IBD… [+59 chars]
[= ] . (Neural Engineering) . , . , , , ·· · · · , , , , . , , , , . (University of Minnesota Twin Cities) (Somatosensory cortex) . , . , , . , . (jaebaekchoi@naver.com) [ . - ]
'' . '(Foralumab)' , T CD3 (mAb) . , T(regulatory T-cells) . (Tiziana Life Sciences) ( TZLS-401 NI-0401) . ( ) , (microglia) . T CD3 , , 1 . " CD3 " . " " " " . …" " , . . , T .… [+249 chars]
, . . (Set Point) . 50kg 55kg . , . , . . , , . . . , . . . , , . . . . , . . , . , , , , . . < > , . , . . , . . . , · ?, . · . , . , , , . . 14 . , . 1~2 24 . = , < >,
0 <ul><li> , </li><li>, '9 ' 1</li><li> TMD </li><li>, (MOU)</li><li>[ ] </li><li>, 5 1 </li><li>, </li><li>[ ] () </li></ul>